A state senator in California is introducing legislation designed to provide more direct oversight over direct-to-consumer genetic testing companies. The new regulations, introduced by Santa Ana’s Democratic Senator Thomas Umberg, builds on attempts in the California Consumer Privacy Act to regulate the ways data collected from genetic testing can be used
Author: Jonathan Shieber
At CAA, Michael Yanover is still betting startups can change Hollywood’s agencies
In a large office scattered with drums, family mementos, and a well-used whiteboard, on the second floor of Creatlve Artist Agency‘s Los Angeles glass, steel, and marble headquarters, Michael Yanover is busy plotting which CAA-repped talent could be the next big entrepreneur. Over a sixteen year career at one of Hollywood’s
Looking to new products, Bev adds strategic investors and redoubles focus on women entrepreneurs
H1 Insights is giving the healthcare industry the ultimate professional database
“I want to build a business which profiles every single researcher and healthcare professional in the world and I want to sell it to industry,” says Ariel Katz, the co-founder and chief executive of H1 Insights. With the healthcare industry on a mission to digitize and analyze every conceivable datapoint it
Oscar Health now has 400,000 members and expects to bring in $2 billion by the end of 2020
Oscar Health, the upstart healthcare insurance company and technology developer, expects to have roughly 400,000 members insured under its healthcare plans, who collectively will bring in roughly $2 billion in revenue for the company by the end of 2020, according to slides of a presentation from the JP Morgan Healthcare
Codagenix raises $20 million for a new flu vaccine and other therapies
Coadagenix, a company developing vaccines and viral therapies for illnesses ranging from the flu and respiratory viruses to dengue fever has raised $20 million in a new round of financing. The company’s new investment round was led by Adjuvant Capital with additional participation from Euclidean Capital and Topspin Partners . Codagenix will
Congratulations 23andMe users, your genes are finally helping the company make drugs
All of that genetic material that 23andMe has been collecting is finally being used for commercial drug development — specifically dermatological drugs. The company inked an agreement with Spanish pharmaceutical developer Almirall, which concentrates on medical dermatology treatments, for the development of dermatological treatments based on an antibody developed by 23andMe. The
Together with portfolio company AMP Robotics, Sidewalk Labs launches recycling pilot in Toronto
At CES, Schneider Electric unveils its own upgrade to the traditional fusebox
As renewable energy and energy efficiency continue to make gains among cost-conscious consumers, more companies are looking at ways to give customers better ways to manage the electricity coming into their homes. At the Consumer Electronics Show in Las Vegas, Schneider Electric unveiled its pitch to homeowners looking for a better
Investors and utilities are seeding carbon markets with new startups
While most of the world agrees that carbon dioxide emissions from human activity are creating a climate crisis, there’s little consensus regarding how to address it. One of the solutions that’s both the most obvious and, seemingly, the most difficult for the international community to agree on is establishing a market